Biopharmaceutical Contract Manufacturings Market Report

Europe Biopharmaceutical Contract Manufacturings Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 23, 2019
  • PAGES：156
  • REPORT CODE：GMM344689
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biopharmaceutical Contract Manufacturings market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Biopharmaceutical Contract Manufacturings Market Segmentations:

    By Player:

    • Boehringer Ingelheim

    • Patheon Inc.

    • Famar

    • Aenova

    • Abbvie Inc

    • Cambrex Corporation.

    • Jubilant Life Sciences Ltd

    • Catalent Inc.

    • Lonza

    • Recipharm AB

    • Baxter Biopharma Solutions.

    • Pfizer Centresource

    By Type:

    • Active Pharmaceutical Ingredient (API) Manufacturing

    • Finished Dosage Formulation (FDF) Development & Manufacturing

    • Others

    By End-User:

    • Oncology

    • Central Nervous System

    • Cardiovascular Disorders

    • Infectious Diseases

    • Pulmonary Disorders

    • Metabolic Disorders

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biopharmaceutical Contract Manufacturings Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing from 2014 to 2026

    • 1.3.2 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing from 2014 to 2026

    • 1.3.3 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Central Nervous System from 2014 to 2026

    • 1.4.3 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Cardiovascular Disorders from 2014 to 2026

    • 1.4.4 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • 1.4.5 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Pulmonary Disorders from 2014 to 2026

    • 1.4.6 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • 1.4.7 Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biopharmaceutical Contract Manufacturings Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biopharmaceutical Contract Manufacturings by Major Types

      • 3.4.1 Market Size and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing

      • 3.4.2 Market Size and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Biopharmaceutical Contract Manufacturings Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biopharmaceutical Contract Manufacturings by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Oncology

      • 4.4.2 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Central Nervous System

      • 4.4.3 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Cardiovascular Disorders

      • 4.4.4 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Infectious Diseases

      • 4.4.5 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Pulmonary Disorders

      • 4.4.6 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Metabolic Disorders

      • 4.4.7 Market Size and Growth Rate of Biopharmaceutical Contract Manufacturings for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Biopharmaceutical Contract Manufacturings Production Analysis by Top Regions

    • 5.2 Europe Biopharmaceutical Contract Manufacturings Consumption Analysis by Top Regions

    • 5.3 Europe Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.3 France Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    6 Product Circulation of Biopharmaceutical Contract Manufacturings Market among Top Countries

    • 6.1 Top 5 Export Countries in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 7.1 Germany Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 7.2 Germany Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    8. UK Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 8.1 UK Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 8.2 UK Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    9. France Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 9.1 France Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 9.2 France Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    10. Italy Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 10.1 Italy Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 10.2 Italy Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    11. Spain Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 11.1 Spain Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 11.2 Spain Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    12. Poland Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 12.1 Poland Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 12.2 Poland Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    13. Russia Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 13.1 Russia Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 13.2 Russia Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    14. Switzerland Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 14.1 Switzerland Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 14.2 Switzerland Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    15. Turkey Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 15.1 Turkey Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 15.2 Turkey Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Landscape Analysis by Top Countries

      • 16.3.1 Denmark Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 16.3.2 Finland Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 16.3.3 Norway Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 16.3.4 Sweden Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 16.3.6 Iceland Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Landscape Analysis by Top Countries

      • 17.3.1 Belgium Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 17.3.2 Netherlands Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 17.3.3 Luxembourg Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Landscape Analysis by Top Countries

      • 18.3.1 Estonia Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 18.3.2 Latvia Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

      • 18.3.3 Lithuania Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Boehringer Ingelheim

      • 19.1.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Patheon Inc.

      • 19.2.1 Patheon Inc. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Famar

      • 19.3.1 Famar Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Aenova

      • 19.4.1 Aenova Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Abbvie Inc

      • 19.5.1 Abbvie Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Cambrex Corporation.

      • 19.6.1 Cambrex Corporation. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Jubilant Life Sciences Ltd

      • 19.7.1 Jubilant Life Sciences Ltd Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Catalent Inc.

      • 19.8.1 Catalent Inc. Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Lonza

      • 19.9.1 Lonza Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Recipharm AB

      • 19.10.1 Recipharm AB Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Baxter Biopharma Solutions.

      • 19.11.1 Baxter Biopharma Solutions. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Pfizer Centresource

      • 19.12.1 Pfizer Centresource Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 73 Figures and 117 Tables)

    • Figure Product Picture

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Central Nervous System from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Cardiovascular Disorders from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Pulmonary Disorders from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Metabolic Disorders from 2014 to 2026

    • Figure Europe Biopharmaceutical Contract Manufacturings Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure France Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Biopharmaceutical Contract Manufacturings Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biopharmaceutical Contract Manufacturings Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biopharmaceutical Contract Manufacturings

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biopharmaceutical Contract Manufacturings by Different Types from 2014 to 2026

    • Table Consumption Share of Biopharmaceutical Contract Manufacturings by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing

    • Figure Market Size and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biopharmaceutical Contract Manufacturings by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biopharmaceutical Contract Manufacturings by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Central Nervous System

    • Figure Market Size and Growth Rate of Cardiovascular Disorders

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Pulmonary Disorders

    • Figure Market Size and Growth Rate of Metabolic Disorders

    • Figure Market Size and Growth Rate of Others

    • Table Europe Biopharmaceutical Contract Manufacturings Production by Major Regions

    • Table Europe Biopharmaceutical Contract Manufacturings Production Share by Major Regions

    • Figure Europe Biopharmaceutical Contract Manufacturings Production Share by Major Countries and Regions in 2014

    • Table Europe Biopharmaceutical Contract Manufacturings Consumption by Major Regions

    • Table Europe Biopharmaceutical Contract Manufacturings Consumption Share by Major Regions

    • Table Germany Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table UK Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table France Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Italy Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Spain Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Poland Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Russia Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Switzerland Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Turkey Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biopharmaceutical Contract Manufacturings Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Germany Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Germany Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Germany Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table UK Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table UK Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table UK Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table UK Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table France Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table France Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table France Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table France Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Italy Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Italy Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Italy Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Italy Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Spain Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Spain Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Spain Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Spain Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Poland Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Poland Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Poland Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Poland Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Russia Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Russia Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Russia Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Russia Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Switzerland Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Switzerland Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Switzerland Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Turkey Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Turkey Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Turkey Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biopharmaceutical Contract Manufacturings Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biopharmaceutical Contract Manufacturings Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biopharmaceutical Contract Manufacturings Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Biopharmaceutical Contract Manufacturings Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Patheon Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Patheon Inc.

    • Figure Sales and Growth Rate Analysis of Patheon Inc.

    • Figure Revenue and Market Share Analysis of Patheon Inc.

    • Table Product and Service Introduction of Patheon Inc.

    • Table Company Profile and Development Status of Famar

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Famar

    • Figure Sales and Growth Rate Analysis of Famar

    • Figure Revenue and Market Share Analysis of Famar

    • Table Product and Service Introduction of Famar

    • Table Company Profile and Development Status of Aenova

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aenova

    • Figure Sales and Growth Rate Analysis of Aenova

    • Figure Revenue and Market Share Analysis of Aenova

    • Table Product and Service Introduction of Aenova

    • Table Company Profile and Development Status of Abbvie Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie Inc

    • Figure Sales and Growth Rate Analysis of Abbvie Inc

    • Figure Revenue and Market Share Analysis of Abbvie Inc

    • Table Product and Service Introduction of Abbvie Inc

    • Table Company Profile and Development Status of Cambrex Corporation.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cambrex Corporation.

    • Figure Sales and Growth Rate Analysis of Cambrex Corporation.

    • Figure Revenue and Market Share Analysis of Cambrex Corporation.

    • Table Product and Service Introduction of Cambrex Corporation.

    • Table Company Profile and Development Status of Jubilant Life Sciences Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Life Sciences Ltd

    • Figure Sales and Growth Rate Analysis of Jubilant Life Sciences Ltd

    • Figure Revenue and Market Share Analysis of Jubilant Life Sciences Ltd

    • Table Product and Service Introduction of Jubilant Life Sciences Ltd

    • Table Company Profile and Development Status of Catalent Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalent Inc.

    • Figure Sales and Growth Rate Analysis of Catalent Inc.

    • Figure Revenue and Market Share Analysis of Catalent Inc.

    • Table Product and Service Introduction of Catalent Inc.

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of Recipharm AB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Recipharm AB

    • Figure Sales and Growth Rate Analysis of Recipharm AB

    • Figure Revenue and Market Share Analysis of Recipharm AB

    • Table Product and Service Introduction of Recipharm AB

    • Table Company Profile and Development Status of Baxter Biopharma Solutions.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter Biopharma Solutions.

    • Figure Sales and Growth Rate Analysis of Baxter Biopharma Solutions.

    • Figure Revenue and Market Share Analysis of Baxter Biopharma Solutions.

    • Table Product and Service Introduction of Baxter Biopharma Solutions.

    • Table Company Profile and Development Status of Pfizer Centresource

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Centresource

    • Figure Sales and Growth Rate Analysis of Pfizer Centresource

    • Figure Revenue and Market Share Analysis of Pfizer Centresource

    • Table Product and Service Introduction of Pfizer Centresource

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US